Page last updated: 2024-10-18

formaldehyde and Invasiveness, Neoplasm

formaldehyde has been researched along with Invasiveness, Neoplasm in 25 studies

paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy

Research Excerpts

ExcerptRelevanceReference
"Restrained expression of miR-106a in gastric cancer cells significantly reduces their capacity of proliferation, migration and invasion."1.40MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer. ( He, S; Lu, G; Lui, Y; Zhang, N; Zhao, L; Zhu, M, 2014)
"The level of brachyury expression in breast cancer cells was positively associated with their ability to invade the extracellular matrix, efficiently form mammospheres in vitro, and resist the cytotoxic effect of docetaxel."1.40Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis. ( Cavaliere, F; Cheng, Q; Costarelli, L; Fernando, RI; Ferroni, P; Guadagni, F; Hamilton, DH; Huang, B; Jochems, C; Litzinger, MT; Lyerly, HK; Palena, C; Roselli, M; Schlom, J; Spila, A; Tsang, KY, 2014)
"The heterogeneity among multiple ductal carcinoma in situ (DCIS) lesions within the same patient also diagnosed with invasive ductal carcinoma (IDC) has not been well evaluated, leaving research implications of intra-individual DCIS heterogeneity yet to be explored."1.40Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients. ( Cai, KQ; Chen, X; Daly, MB; Devarajan, K; Jiang, Z; Pape-Zambito, D; Patchefsky, A; Slater, CM; Wu, H, 2014)
"MiR-221 is over-expressed in human hepatocellular carcinoma (HCC), but its clinical significance and function in HCC remains uncertain."1.39Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro. ( Chen, G; Dang, Y; Rong, M, 2013)
"However, breast cancer is a diverse disease and little is known about the relationships between miRNA expression, clinical outcome and tumour subtype."1.38Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue. ( Ali, HR; Bardwell, H; Blows, F; Caldas, C; Dawson, SJ; Jones, J; Pharoah, P; Quesne, JL; Warren, J, 2012)
"Ten palpable invasive breast carcinomas were resected and underwent immediate gross evaluation."1.38Delay to formalin fixation alters morphology and immunohistochemistry for breast carcinoma. ( Khoury, T, 2012)
"In patients with esophageal squamous cell carcinoma, there appears to be an inverse relationship between nm23-H1 gene product expression and lymphatic vessel invasion."1.31Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival. ( Ayabe, T; Edagawa, M; Hara, M; Maeda, M; Matsuzaki, Y; Onitsuka, T; Shimizu, T; Tomita, M, 2001)

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (16.00)18.2507
2000's3 (12.00)29.6817
2010's17 (68.00)24.3611
2020's1 (4.00)2.80

Authors

AuthorsStudies
Kalloger, SE1
Karasinska, JM1
Keung, MS1
Thompson, DL1
Ho, J1
Chow, C1
Gao, D1
Topham, JT1
Warren, C1
Wong, HL1
Lee, MK1
Renouf, DJ1
Schaeffer, DF1
Soon, PS1
Provan, PJ1
Kim, E1
Pathmanathan, N1
Graham, D1
Clarke, CL1
Balleine, RL1
Chin, SF1
Santonja, A1
Grzelak, M1
Ahn, S1
Sammut, SJ1
Clifford, H1
Rueda, OM1
Pugh, M1
Goldgraben, MA1
Bardwell, HA1
Cho, EY1
Provenzano, E1
Rojo, F1
Alba, E1
Caldas, C2
Tabyaoui, I1
Tahiri-Jouti, N1
Serhier, Z1
Bennani-Othmani, M1
Sibai, H1
Itri, M1
Benchekroun, S1
Zamiati, S1
Zhu, M1
Zhang, N1
He, S1
Lui, Y1
Lu, G1
Zhao, L1
Zuo, P1
Ma, Y1
Huang, Y1
Ye, F1
Wang, P1
Wang, X1
Zhou, C1
Lu, W1
Kong, B1
Xie, X1
Palena, C1
Roselli, M1
Litzinger, MT1
Ferroni, P1
Costarelli, L1
Spila, A1
Cavaliere, F1
Huang, B1
Fernando, RI1
Hamilton, DH1
Jochems, C1
Tsang, KY1
Cheng, Q1
Lyerly, HK1
Schlom, J1
Guadagni, F1
Pape-Zambito, D1
Jiang, Z1
Wu, H1
Devarajan, K1
Slater, CM1
Cai, KQ1
Patchefsky, A1
Daly, MB1
Chen, X2
Hagen, RM1
Adamo, P1
Karamat, S1
Oxley, J1
Aning, JJ1
Gillatt, D1
Persad, R1
Ladomery, MR1
Rhodes, A1
Yan, SY1
Hu, Y1
Fan, JG1
Tao, GQ1
Lu, YM1
Cai, X1
Yu, BH1
Du, YQ1
Deftereos, G1
Corrie, SR1
Feng, Q1
Morihara, J1
Stern, J1
Hawes, SE1
Kiviat, NB1
Quesne, JL1
Jones, J1
Warren, J1
Dawson, SJ1
Ali, HR1
Bardwell, H1
Blows, F1
Pharoah, P1
Yamamoto, S1
Ibusuki, M1
Yamamoto, Y1
Fu, P1
Fujiwara, S1
Murakami, K1
Iwase, H1
Khoury, T1
Gorman, BK1
Kosarac, O1
Chakraborty, S1
Schwartz, MR1
Mody, DR1
He, C1
Jiang, H1
Geng, S1
Sheng, H1
Shen, X1
Zhang, X1
Zhu, S1
Yang, C1
Gao, H1
Beltran, H1
Yelensky, R1
Frampton, GM1
Park, K1
Downing, SR1
MacDonald, TY1
Jarosz, M1
Lipson, D1
Tagawa, ST1
Nanus, DM1
Stephens, PJ1
Mosquera, JM1
Cronin, MT1
Rubin, MA1
Rong, M1
Chen, G1
Dang, Y1
Selvarajan, S1
Bay, BH1
Choo, A1
Chuah, KL1
Sivaswaren, CR1
Tien, SL1
Wong, CY1
Tan, PH1
Roomi, MW1
Roomi, N1
Ivanov, V1
Kalinovsky, T1
Niedzwiecki, A1
Rath, M1
Piffkó, J1
Bánkfalvi, A1
Ofner, D1
Berens, A1
Tkotz, T1
Joos, U1
Böcker, W1
Schmid, KW1
Saenz-Santamaría, MC1
McNutt, NS1
Bogdany, JK1
Shea, CR1
Allison, RT1
Best, T1
Tomita, M1
Ayabe, T1
Matsuzaki, Y1
Edagawa, M1
Maeda, M1
Shimizu, T1
Hara, M1
Onitsuka, T1
Gijbels, MJ1
Visser, JW1
Solleveld, HA1
Broerse, JJ1
Zurcher, C1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
"A Randomized Multicenter Phase II Trial to Evaluate the Effectiveness of Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients"[NCT00432172]Phase 2189 participants (Actual)Interventional2007-04-24Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Clinical Response Rate

Clinical Response Rate was measured according to the Response Evaluation Criteria in Solid Tumors (RECIST) Criteria for target lesions before surgery: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), >=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR. (NCT00432172)
Timeframe: Up to week 24

InterventionParticipants (Count of Participants)
Group 1 (Luminal A) Standard Treatment31
Group 1 (Luminal A) Selective Treatment23
Group 2 (Basal) Standard Treatment32
Group 2 (Basal) Selective Treatment36

Other Studies

25 other studies available for formaldehyde and Invasiveness, Neoplasm

ArticleYear
Stroma vs epithelium-enhanced prognostics through histologic stratification in pancreatic ductal adenocarcinoma.
    International journal of cancer, 2021, 01-15, Volume: 148, Issue:2

    Topics: Carcinoma, Pancreatic Ductal; Cluster Analysis; Cohort Studies; Epithelial Cells; Formaldehyde; Gene

2021
Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
    Clinical & experimental metastasis, 2018, Volume: 35, Issue:1-2

    Topics: Adult; Aged; Axilla; Blood Vessels; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraduc

2018
Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers.
    Experimental and molecular pathology, 2018, Volume: 104, Issue:3

    Topics: Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; DNA; DNA Copy Number Variations; Female;

2018
Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data.
    Diagnostic pathology, 2013, Feb-27, Volume: 8

    Topics: Adolescent; Biomarkers, Tumor; Cell Differentiation; Chi-Square Distribution; Child; Child, Preschoo

2013
MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer.
    FEBS letters, 2014, Feb-14, Volume: 588, Issue:4

    Topics: Base Sequence; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Formaldehyde; Gene Knock

2014
High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer.
    Gynecologic oncology, 2014, Volume: 132, Issue:3

    Topics: Actins; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cytoskeleton; Disease-Free S

2014
Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.
    Journal of the National Cancer Institute, 2014, May-09, Volume: 106, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cell Line, Tumor; Epithelial-Mesenchymal Transitio

2014
Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrat

2014
Quantitative analysis of ERG expression and its splice isoforms in formalin-fixed, paraffin-embedded prostate cancer samples: association with seminal vesicle invasion and biochemical recurrence.
    American journal of clinical pathology, 2014, Volume: 142, Issue:4

    Topics: Alternative Splicing; Exons; Formaldehyde; Gene Expression Regulation, Neoplastic; Humans; Immunohis

2014
Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma.
    World journal of gastroenterology, 2011, Mar-21, Volume: 17, Issue:11

    Topics: Adenocarcinoma; Biomarkers, Tumor; China; Female; Fixatives; Formaldehyde; Gene Amplification; Gene

2011
Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer.
    PloS one, 2011, Volume: 6, Issue:12

    Topics: Cell Line, Tumor; Cervix Uteri; Female; Formaldehyde; Gene Expression Profiling; Gene Expression Reg

2011
Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.
    The Journal of pathology, 2012, Volume: 227, Issue:3

    Topics: Biomarkers, Tumor; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chi-Squa

2012
Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
    Breast cancer (Tokyo, Japan), 2013, Volume: 20, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Female; Formaldehyde; Gene Expr

2013
Delay to formalin fixation alters morphology and immunohistochemistry for breast carcinoma.
    Applied immunohistochemistry & molecular morphology : AIMM, 2012, Volume: 20, Issue:6

    Topics: Biomarkers; Breast Neoplasms; Female; Formaldehyde; Humans; Immunohistochemistry; Neoplasm Invasiven

2012
Comparison of breast carcinoma prognostic/predictive biomarkers on cell blocks obtained by various methods: Cellient, formalin and thrombin.
    Acta cytologica, 2012, Volume: 56, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy, Fine-Needle; Breast Neoplasms; Cytodiagno

2012
Expression of c-Myc and Fas correlates with perineural invasion of pancreatic cancer.
    International journal of clinical and experimental pathology, 2012, Volume: 5, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Chi-Square Distribution; China; fas Receptor; Fem

2012
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
    European urology, 2013, Volume: 63, Issue:5

    Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Biopsy, Needle; Drug Resistance, Neoplasm; Ex

2013
Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.
    BMC cancer, 2013, Jan-16, Volume: 13

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Apoptosis; Carcinoma, Hepatocellular; Caspase

2013
Effect of fixation period on HER2/neu gene amplification detected by fluorescence in situ hybridization in invasive breast carcinoma.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2002, Volume: 50, Issue:12

    Topics: Breast Neoplasms; Female; Fixatives; Formaldehyde; Gene Amplification; Genes, erbB-2; Humans; In Sit

2002
Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis.
    Oncology reports, 2005, Volume: 14, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Cell Line, Tumor; Cell Proli

2005
Expression of p53 protein in oral squamous cell carcinomas and adjacent non-tumorous mucosa of the floor of the mouth: an archival immunohistochemical study using wet autoclave pretreatment for antigen retrieval.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1995, Volume: 24, Issue:8

    Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Carcinoma, Squamous Cell; Female; Fixatives; Follow-Up S

1995
p53 expression is rare in cutaneous melanomas.
    The American Journal of dermatopathology, 1995, Volume: 17, Issue:4

    Topics: Aged; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Division; Cell Nucleus; Fixatives; Formaldehy

1995
p53, PCNA and Ki-67 expression in oral squamous cell carcinomas: the vagaries of fixation and microwave enhancement of immunocytochemistry.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1998, Volume: 27, Issue:9

    Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Cytoplasm; Disease Progression; Epithelial Cells; Ethan

1998
Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival.
    BMC cancer, 2001, Volume: 1

    Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fixatives; Formaldehyde;

2001
Flow cytometric DNA measurement and cytomorphometric analysis of formalin fixed rat mammary tumours.
    British journal of cancer, 1991, Volume: 64, Issue:3

    Topics: Adenocarcinoma; Adenoma; Animals; Carcinoma, Papillary; DNA, Neoplasm; Female; Flow Cytometry; Forma

1991